References
- Martin W. R., Eades C. G., Thompson J. A., Hueppler R. E., Gilbert P. E. The effects of morphine and nalorphine‐like drugs in nondependent and morphine‐dependent chronic spinal dog. J. Pharmac. exp. Ther. 1976; 197: 517–532
- Lord J. A. H., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides‐multiple agonists and receptors. Nature 1977; 267: 495–498
- Chavkin C., James I., Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 1982; 215: 413–415
- Quirion R., Pilapil C. Opioid receptor binding profile of [3H]dynorphin A (1–8) in rat and guinea pig brain. Eur. J. Pharmac. 1984; 99: 361–363
- Gillan M. G. C., Robson L. E., McKnight A. T., Kosterlitz H. W. K‐Binding and degradation of [3H]dynorphin A (1–8) and [3H]dynorphin A (1–9) in suspensions of guinea pig brain membranes. J. Neurochem. 1985; 45: 1034–1042
- Corbett A. D., Paterson S. J., McKnight A. T., Magnan J., Kosterlitz H. W. Dynorphin1–8 and dynorphin1–9 are ligands for the K‐subtype of opiate receptor. Nature 1982; 299: 79–81
- Foote R. W., Maurer R. Autoradiographic localization of opiate k‐receptors in the guinea pig brain. Eur. J. Pharmac. 1982; 85: 99–103
- Goodman R. R., Snyder S. H. Autoradiographic localization of kappa opiate receptors to deep layers of the cerebral cortex may explain unique sedative and analgesic effects. Life Sci. 1982; 31: 1291–1296
- Herkenham M. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience 1987; 23: 1–38
- Kosterlitz H. W., Paterson S. J., Robson L. E. Characterization of the K‐subtype of the opiate receptor in the guinea‐pig brain. Br. J. Pharmac. 1981; 73: 939–949
- Maurer R. Multiplicity of opiate receptors in different species. Neurosci. Lett. 1982; 30: 303–307
- Kosterlitz H. W., Paterson S. J. Characterization of opioid receptors in nervous tissue. Proc. Roy. Soc. Lond. 1980; 210: 113–122
- Wood P. L., Charleston S., Lane D., Hudgin R. L. Multiple opiate receptors: support of unique mu, delta, and kappa sites. Neuropharmacology 1982; 21: 487–497
- Pfeiffer A., Herz A. Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10047. Biochem. Biophys. Res. Commun. 1981; 101: 38–44
- Wolozin B. L., Nishimura S., Pasternak G. W. The binding of K‐, and σ‐opiates in rat brain. J. Neurosci. 1982; 2: 708–713
- Roemer D., Buscher H., Hill R. C., Maurer R., Petcher T. J., Welle H. B. A., Bakel H. C.E.K., Akkerman A. M. Bremazocine: a potent long‐acting opiate kappa agonist. Life Sci. 1980; 27: 971–978
- Young E. A., Walker J. M., Houghten R., Akil H. [3H]Dynorphin A binds selectively to guinea pig brain. Eur. J. Pharmac. 1980; 91: 327–333
- Sharif N. A., Hunter J. C., Hill R. G., Hughes J. [125I]Dynorphin(1–8) produces a similar pattern of K‐opioid receptor labelling to [3H]dynorphin(1–8) and [3H] etorphine in guinea pig brain: a quantitative autoradiographic study. Neurosci. Lett. 1988; 86: 272–278
- Zamir N., Palkovits M., Brownstein M. J. Distribution of immunoreactive dynorphinA1–8 in discrete nuclei of the rat brain: comparison with dynorphinA. Brain Res. 1984; 307: 61–68
- Khachaturian H., Watson S. J., Lewis M. E., Coy D., Goldstein A., Akil H. Dynorphin immunohistochemistry in the rat central nervous system. Peptides 1982; 3: 941–954
- Vincent S. R., Hokfelt T., Christensson I., Terenius L. Dynorphin‐immunoreactive neurons in the central nervous system of the rat. Neurosci. Lett. 1983; 33: 185–190
- Slater P., Cross A. J. Autoradiographic distribution of dynorphin1–9 binding sites in primate brain. Neuropeptides 1986; 8: 71–76